Provinciali et al. studied the effect of a complex of silybin with phosphatidylcholine, Silipide®, which confers a higher bioavailability compared to silymarin, as previously shown in healthy human subjects [16], on the development of mammary tumors appearing spontaneously in HER-2/neu transgenic mice. The gene discussed is ERBB2; the disease is breast cancer.